デフォルト表紙
市場調査レポート
商品コード
1413662

血管パッチ市場、素材別、用途別 - 2024年~2030年の世界予測

Vascular Patches Market by Material (Biologic Vascular Patches, Synthetic Vascular Patches), Application (Carotid Endarterectomy, Open Repair of Abdominal Aneurysm, Peripheral Vascular Reconstruction) - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 190 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.87円
血管パッチ市場、素材別、用途別 - 2024年~2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血管パッチ市場、素材別、用途別市場規模は、2023年に3億9,992万米ドルと推定され、2024年には4億3,416万米ドルに達し、CAGR 7.99%で2030年には6億8,515万米ドルに達すると予測されています。

血管パッチ市場、素材別、用途別の世界市場

主な市場の統計
基準年[2023年] 3億9,992万米ドル
予測年[2024年] 4億3,416万米ドル
予測年[2030年] 6億8,515万米ドル
CAGR(%) 7.99%
血管パッチ市場、素材別、用途別 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは血管パッチ市場、素材別、用途別市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、血管パッチ市場、素材別、用途別市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1-市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1-血管パッチ市場、素材別、用途別の市場規模および予測は?

2-血管パッチ市場、素材別、用途別の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3-血管パッチ市場、素材別、用途別における技術動向と規制の枠組みは?

4-血管パッチ市場、素材別、用途別における主要ベンダーの市場シェアは?

5-血管パッチ市場、素材別、用途別への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 血管疾患と凝固障害の有病率の上昇
      • 医療機器の毒性を軽減するための生体適合性材料のニーズの高まり
    • 抑制要因
      • パッチの信頼性低下による製品リコールの事例
    • 機会
      • 組織工学と3Dテクノロジーの進歩
      • 幹細胞調査と血管パッチ市場、素材別、用途別の作成のための幹細胞技術の使用に対する関心の高まり
    • 課題
      • 血管パッチ市場、素材別、用途別の安定性に関する規制上の問題
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 血管パッチ市場、素材別、用途別:素材別

  • 生物学的血管パッチ市場、素材別、用途別
  • 合成血管パッチ

第7章 血管パッチ市場、素材別、用途別:用途別

  • 頸動脈内膜切除術
  • 腹部動脈瘤の観血的修復
  • 末梢血管再建
  • 血管バイパス手術

第8章 南北アメリカの血管パッチ市場、素材別、用途別

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋の血管パッチ市場、素材別、用途別

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの血管パッチ市場、素材別、用途別

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ主要企業別の分析

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Aegis Lifesciences Private Limited
    • Artivion, Inc
    • AVOMA GROUP
    • Axio Biosolutions Pvt Ltd
    • B. Braun SE
    • Baxter International, Inc.
    • Becton, Dickinson and Company
    • Braile Biomedica
    • Celox Medical by Medtrade Products Ltd.
    • CryoLife
    • Edwards Lifesciences Corporation
    • Getinge AB
    • Labcor Laboratorios Ltda.
    • LeMaitre Vascular, Inc.
    • Obex Medical Limited
    • Solinas Medical Inc.
    • Terumo Corporation
    • VUP Medical, a.s.
    • W. L. Gore & Associates, Inc.
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. VASCULAR PATCHES MARKET RESEARCH PROCESS
  • FIGURE 2. VASCULAR PATCHES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. VASCULAR PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. VASCULAR PATCHES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. VASCULAR PATCHES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. VASCULAR PATCHES MARKET DYNAMICS
  • FIGURE 7. VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
  • FIGURE 8. VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS VASCULAR PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS VASCULAR PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES VASCULAR PATCHES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES VASCULAR PATCHES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC VASCULAR PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC VASCULAR PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VASCULAR PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VASCULAR PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. VASCULAR PATCHES MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. VASCULAR PATCHES MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. VASCULAR PATCHES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. VASCULAR PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VASCULAR PATCHES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 6. VASCULAR PATCHES MARKET SIZE, BY BIOLOGIC VASCULAR PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. VASCULAR PATCHES MARKET SIZE, BY SYNTHETIC VASCULAR PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 9. VASCULAR PATCHES MARKET SIZE, BY CAROTID ENDARTERECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. VASCULAR PATCHES MARKET SIZE, BY OPEN REPAIR OF ABDOMINAL ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. VASCULAR PATCHES MARKET SIZE, BY PERIPHERAL VASCULAR RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. VASCULAR PATCHES MARKET SIZE, BY VASCULAR BYPASS SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS VASCULAR PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES VASCULAR PATCHES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC VASCULAR PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA VASCULAR PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM VASCULAR PATCHES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM VASCULAR PATCHES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VASCULAR PATCHES MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 100. VASCULAR PATCHES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. VASCULAR PATCHES MARKET LICENSE & PRICING
目次
Product Code: MRR-B16853779455

[190 Pages Report] The Vascular Patches Market size was estimated at USD 399.92 million in 2023 and expected to reach USD 434.16 million in 2024, at a CAGR 7.99% to reach USD 685.15 million by 2030.

Global Vascular Patches Market

KEY MARKET STATISTICS
Base Year [2023] USD 399.92 million
Estimated Year [2024] USD 434.16 million
Forecast Year [2030] USD 685.15 million
CAGR (%) 7.99%
Vascular Patches Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Vascular Patches Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Vascular Patches Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Vascular Patches Market, highlighting leading vendors and their innovative profiles. These include Aegis Lifesciences Private Limited, Artivion, Inc, AVOMA GROUP, Axio Biosolutions Pvt Ltd, B. Braun SE, Baxter International, Inc., Becton, Dickinson and Company, Braile Biomedica, Celox Medical by Medtrade Products Ltd., CryoLife, Edwards Lifesciences Corporation, Getinge AB, Labcor Laboratorios Ltda., LeMaitre Vascular, Inc., Obex Medical Limited, Solinas Medical Inc., Terumo Corporation, VUP Medical, a.s., and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Vascular Patches Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Material
    • Biologic Vascular Patches
    • Synthetic Vascular Patches
  • Application
    • Carotid Endarterectomy
    • Open Repair of Abdominal Aneurysm
    • Peripheral Vascular Reconstruction
    • Vascular Bypass Surgery
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Vascular Patches Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Vascular Patches Market?

3. What are the technology trends and regulatory frameworks in the Vascular Patches Market?

4. What is the market share of the leading vendors in the Vascular Patches Market?

5. Which modes and strategic moves are suitable for entering the Vascular Patches Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Vascular Patches Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of vascular diseases and clotting disorders
      • 5.1.1.2. Growing need for biocompatible material to reduce the toxicity of medical devices
    • 5.1.2. Restraints
      • 5.1.2.1. Instances of product recall due to reduced reliability of patches
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in tissue engineering and 3D technology
      • 5.1.3.2. Growing interest in stem cell research and the use of stem cell technology for the production of vascular patches
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory issues concerning the stability of vascular patches
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Vascular Patches Market, by Material

  • 6.1. Introduction
  • 6.2. Biologic Vascular Patches
  • 6.3. Synthetic Vascular Patches

7. Vascular Patches Market, by Application

  • 7.1. Introduction
  • 7.2. Carotid Endarterectomy
  • 7.3. Open Repair of Abdominal Aneurysm
  • 7.4. Peripheral Vascular Reconstruction
  • 7.5. Vascular Bypass Surgery

8. Americas Vascular Patches Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Vascular Patches Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Vascular Patches Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Aegis Lifesciences Private Limited
    • 12.1.2. Artivion, Inc
    • 12.1.3. AVOMA GROUP
    • 12.1.4. Axio Biosolutions Pvt Ltd
    • 12.1.5. B. Braun SE
    • 12.1.6. Baxter International, Inc.
    • 12.1.7. Becton, Dickinson and Company
    • 12.1.8. Braile Biomedica
    • 12.1.9. Celox Medical by Medtrade Products Ltd.
    • 12.1.10. CryoLife
    • 12.1.11. Edwards Lifesciences Corporation
    • 12.1.12. Getinge AB
    • 12.1.13. Labcor Laboratorios Ltda.
    • 12.1.14. LeMaitre Vascular, Inc.
    • 12.1.15. Obex Medical Limited
    • 12.1.16. Solinas Medical Inc.
    • 12.1.17. Terumo Corporation
    • 12.1.18. VUP Medical, a.s.
    • 12.1.19. W. L. Gore & Associates, Inc.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing